Febrile Neutropenia

Febrile neutropenia is a potentially life-threatening condition characterized by fever in a patient with an abnormally low neutrophil count, commonly occurring in patients undergoing chemotherapy or with hematologic malignancies.

Definition

Febrile neutropenia is a potentially life-threatening condition characterized by fever in a patient with an abnormally low neutrophil count, commonly occurring in patients undergoing chemotherapy or with hematologic malignancies.

Epidemiology

  • Common complication in patients receiving cytotoxic chemotherapy (10–50% depending on regimen)
  • Higher risk in hematologic malignancies than solid tumors
  • Incidence increases with advanced age and comorbidities
  • Associated with increased morbidity, prolonged hospitalization, and mortality (5–20%)
  • More frequent in patients with prolonged or profound neutropenia (<500/µL)

Etiology

  • Chemotherapy-induced myelosuppression is the most common cause
  • Hematologic malignancies causing marrow suppression
  • Bone marrow transplant recipients
  • Immunosuppressive therapy (corticosteroids, biologics)
  • Infections by bacteria, viruses, fungi, or rarely parasites; often bacterial in origin (Gram-negative rods, Gram-positive cocci)

Pathophysiology

  • Cytotoxic therapy or disease suppresses bone marrow, reducing neutrophil production
  • Neutropenia impairs innate immune response, decreasing ability to control infections
  • Even minor infections can rapidly progress due to impaired host defense
  • Fever may be the only sign of infection due to blunted inflammatory response
  • Rapid escalation of infection can lead to sepsis, multi-organ failure, and death if untreated
Messenger Icon